Correlation of serum lGF-I and IGFBP-1 and-3 to cardiovascular risk indicators and early carotid atherosclerosis in healthy middle-aged men

被引:43
作者
Boquist, S. [1 ,2 ]
Ruotolo, G. [3 ]
Skoglund-Andersson, C. [2 ]
Tang, R. [4 ]
Bjorkegren, J. [2 ]
Bond, M. G. [4 ]
de Faire, U. [5 ]
Brismar, K. [6 ]
Hamsten, A. [1 ,2 ]
机构
[1] Karolinska Univ Hosp Solna, Dept Med, Cardiol Unit, SE-17176 Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Med, King Gustaf V Res Inst, Atherosclerosis Res Unit,Karolinska Inst, Stockholm, Sweden
[3] Ist Sci San Raffaele, Cardiovasc Dept, I-20132 Milan, Italy
[4] Wake Forest Univ, Bowman Gray Sch Med, Div Ultrasound Res, Winston Salem, NC USA
[5] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, Stockholm, Sweden
[6] Karolinska Univ Hosp, Karolinska Inst, Dept Mol Med & Surg, Endocrinol & Diabetol Unit, Stockholm, Sweden
关键词
D O I
10.1111/j.1365-2265.2007.02998.x
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Objectives IGF-I, IGFBP-1 and IGFBP-3 are putative mediators in cardiovascular disease. The present study examined (i) the correlations of circulating IGF-I, IGFBP-1 and IGFBP-3 to established cardiovascular risk factors and signs of early atherosclerosis as reflected by ultrasound measurement of common carotid intima-media thickness (IMT), and (ii) whether serum concentrations of these analytes are modulated during alimentary lipaemia. Design Cross-sectional clinical study. Patients A biobank and clinical database based on 96 healthy Caucasian men, aged 50 years, with an apolipoprotein (apo) E3/E3 genotype, who had originally undergone investigations of postprandial lipoprotein metabolism was used for the study. Measurements Total IGF-I, IGFBP-1 and IGFBP-3 were determined in serum by radioimmunoassay (RIA). Free IGF-I was measured by a commercial two-site immunoradiometric assay (IRMA). Results In multivariate analyses, fasting serum free IGF-I correlated inversely with IMT and accounted for 5% of the variation in multiple R-2. When fasting serum IGFBP-1 was entered in the models instead of IGF-I, IGFBP-1 correlated positively with IMT and accounted for 6% of the variation in IMT. IGFBP-3 and total IGF-I were unrelated to IMT. There were no associations between free IGF-I and cardiovascular risk factors, whereas IGFBP-1 behaved like a component of the insulin resistance syndrome. Serum free IGF-I increased and IGFBP-1 decreased postprandially. Conclusion The data indicate that serum free IGF-I and IGFBP-1 are implicated in early atherosclerosis.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 35 条
[1]
COMPARISON OF ACID ETHANOL EXTRACTION AND ACID GEL-FILTRATION PRIOR TO IGF-I AND IGF-II RADIOIMMUNOASSAYS - IMPROVEMENT OF DETERMINATIONS IN ACID ETHANOL EXTRACTS BY THE USE OF TRUNCATED IGF-I AS RADIOLIGAND [J].
BANG, P ;
ERIKSSON, U ;
SARA, V ;
WIVALL, IL ;
HALL, K .
ACTA ENDOCRINOLOGICA, 1991, 124 (06) :620-629
[2]
Insulin-like growth factor (IGF)-binding proteins: interactions with IGFs and intrinsic bioactivities [J].
Baxter, RC .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2000, 278 (06) :E967-E976
[3]
The insulin-like growth factor axis - A review of atherosclerosis and restenosis [J].
Bayes-Genis, A ;
Conover, CA ;
Schwartz, RS .
CIRCULATION RESEARCH, 2000, 86 (02) :125-130
[4]
Alimentary lipemia, postprandial triglyceride-rich lipoproteins, and common carotid intima-media thickness in healthy, middle-aged men [J].
Boquist, S ;
Ruotolo, G ;
Tang, R ;
Björkegren, J ;
Bond, MG ;
de Faire, U ;
Karpe, F ;
Hamsten, A .
CIRCULATION, 1999, 100 (07) :723-728
[5]
Insulin and non-esterified fatty acid relations to alimentary lipaemia and plasma concentrations of postprandial triglyceride-rich lipoproteins in healthy middle-aged men [J].
Boquist, S ;
Hamsten, A ;
Karpe, E ;
Ruotolo, G .
DIABETOLOGIA, 2000, 43 (02) :185-193
[6]
INSULIN-LIKE GROWTH FACTOR-I AND FACTOR-II - PEPTIDE, MESSENGER RIBONUCLEIC-ACID AND GENE STRUCTURES, SERUM, AND TISSUE CONCENTRATIONS [J].
DAUGHADAY, WH ;
ROTWEIN, P .
ENDOCRINE REVIEWS, 1989, 10 (01) :68-91
[7]
Cardiovascular disease and insulin-like growth factor I [J].
Frystyk, J ;
Ledet, T ;
Moller, N ;
Flyvbjerg, A ;
Orskov, H .
CIRCULATION, 2002, 106 (08) :893-895
[8]
Reduced insulin-like growth factor binding protein-1 (IGFBP-1) levels correlate with increased cardiovascular risk in noninsulin dependent diabetes mellitus (NIDDM). [J].
Gibson, JM ;
Westwood, M ;
Young, RJ ;
White, A .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (02) :860-863
[9]
High serum insulin-like growth factor binding protein-1 is associated with increased cardiovascular mortality in elderly men [J].
Harrela, M ;
Qiao, Q ;
Koistinen, R ;
Tuomilehto, J ;
Nissinen, A ;
Seppälä, M ;
Leinonen, P .
HORMONE AND METABOLIC RESEARCH, 2002, 34 (03) :144-149
[10]
Close relation of fasting insulin-like growth factor binding protein-1 (IGFBP-1) with glucose tolerance and cardiovascular risk in two populations [J].
Heald, AH ;
Cruickshank, JK ;
Riste, LK ;
Cade, JE ;
Anderson, S ;
Greenhalgh, A ;
Sampayo, J ;
Taylor, W ;
Fraser, W ;
White, A ;
Gibson, JM .
DIABETOLOGIA, 2001, 44 (03) :333-339